To identify the varying expression levels of these two exhausted CD8+ T cell types, we used multiplex immunohistochemistry method of marker genes (CD3, CD8, PDCD1, XBP1) in paraffin slices from 18 iCCA patients who were treated with anti-PD1 therapy. This evidence concerns the gene XBP1 and infantile convulsions and choreoathetosis.